ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

DARE Dare Bioscience Inc

0,4401
0,0052 (1,20%)
18 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Dare Bioscience Inc DARE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,0052 1,20% 0,4401 23:06:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,44 0,424514 0,44 0,43 0,4349
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.6.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202422:05EDGAR2Form 8-K - Current report
14.5.202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.5.202414:05EDGAR2Form 8-K - Current report
14.5.202414:00GLOBEDaré Bioscience Reports First Quarter 2024 Financial Results..
13.5.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10.5.202422:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07.5.202414:00GLOBEDaré Bioscience to Host First Quarter 2024 Financial Results..
02.5.202414:00GLOBEDaré Bioscience Selected as a Member of ARPA-H Investor..
30.4.202413:30GLOBEDaré Bioscience Secures $22 Million in Non-Dilutive..
23.4.202414:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
11.4.202414:00GLOBEDaré Bioscience Announces Publication in Contraception of..
28.3.202413:00GLOBEDaré Bioscience Reports Full Year 2023 Financial Results and..
28.3.202412:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
21.3.202413:00GLOBEDaré Bioscience to Host Full Year 2023 Financial Results and..
22.2.202414:00GLOBEDaré Bioscience to Present at the International Society for..
31.1.202414:00GLOBEDaré Bioscience Announces Positive End-of-Phase 2 Meeting..
26.1.202423:15EDGAR2Form 8-K - Current report
26.1.202422:30GLOBEDaré Bioscience Announces Executive Team and Board of..
19.1.202422:30EDGAR2Form 8-K - Current report
17.1.202414:00GLOBEDaré Bioscience Announces Grant to Support Biotherapeutic..
08.1.202414:00EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEDaré Bioscience’s DARE-LARC1 Platform Technology Achieves..
26.12.202314:05EDGAR2Form 8-K - Current report
26.12.202314:00GLOBEDaré Bioscience Secures $12 million in Royalty-backed..
20.12.202314:05EDGAR2Form 8-K - Current report
20.12.202314:00GLOBEDaré Bioscience Announces Positive Topline Pharmacokinetic..
13.12.202314:00GLOBEDaré Bioscience Announces Funding Award Notice from the..
07.12.202314:00GLOBEDaré Bioscience Announces FDA Clearance of Investigational..
04.12.202314:00GLOBEDaré Bioscience Announces Commencement of Phase 3 Study of..
20.11.202314:00GLOBEDaré Bioscience and Premier Research Extend Strategic..
13.11.202314:00GLOBEDaré Bioscience to Present at the Sexual Medicine Society of..
09.11.202323:15EDGAR2Form 8-K - Current report
09.11.202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:05EDGAR2Form 8-K - Current report
09.11.202314:00GLOBEDaré Bioscience Reports Third Quarter 2023 Financial Results..
06.11.202314:00GLOBEDaré Bioscience to Participate in Three November Conferences
02.11.202313:00GLOBEDaré Bioscience to Host Third Quarter 2023 Financial Results..
01.11.202313:05EDGAR2Form 8-K - Current report
01.11.202313:00GLOBEDaré Bioscience Announces Additional Positive Data from..
16.10.202314:15EDGAR2Form 8-K - Current report
16.10.202314:00GLOBEDaré Bioscience Announces Achievement of First Commercial..
21.9.202314:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
20.9.202314:00GLOBEDaré Bioscience to Present at The Menopause Society 2023..
11.9.202314:15EDGAR2Form 8-K - Current report
06.9.202314:00GLOBEDaré Bioscience to Participate in Upcoming Investor..
05.9.202314:00GLOBEDaré Bioscience Completes Previously Announced Equity..
30.8.202323:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Kürzlich von Ihnen besucht

Delayed Upgrade Clock